Allosteric modulators of the AMPA receptor: Novel 6-substituted dihydrophthalazines

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 4, 1999, Pages 539-542

  Pei, Xue Feng ^a   Sturgess, Michael A ^a   Fernando Valenzuela, C ^a,b   Maccecchini, Maria Luisa ^a  

^a Bearsden Bio Inc   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR ANTAGONIST; KAINIC ACID; PHTHALAZINE DERIVATIVE; SYM 2187; SYM 2189; SYM 2206; SYM 2207; SYM 2230; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; MOUSE; NONHUMAN; RAT; RECEPTOR BLOCKING; STRUCTURE ACTIVITY RELATION;

ALLOSTERIC REGULATION; ANIMALS; CELLS, CULTURED; MICE; NEURONS; PHTHALAZINES; RATS; RECEPTORS, AMPA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033593926     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00044-X     Document Type: Article

References (25)

1. 1. Hicks, T. P. In CNS Neurotransmitter and Neuromodulators: Glutamate; Stone, T. W., Ed.; CRC: New York, 1995; pp 201-215.
2. 2. (a) Olney, J. W. Annu. Rev. Pharmacol. 1990, 30, 47.
3. (b) Choi, D. W. Neuron 1988, 1, 623.
4. (c) Meldrum, B. Brain Res. Rev. 1993, 18, 293.
5. (d) Olney, J. W. Neurobiol. Aging 1994, 15, 259.
6. 3. (a) Lipton, S. A.; Rosenberg, P. A. N. Engl. J. Med. 1994, 330, 613.
7. (b) Ikonomidou, C.; Turski, L. In CNS Neurotransmitters and Neuropmodulators: Glutamate; Stone T. W., Ed.; CRC: New York, 1995; pp 253-266.
8. (c) Szatkowski, M.; Attwell, D. Trends Neurosci. 1994, 17, 359.
9. 4. (a) Meldrum, B. S. In Direct and Allosteric Control of Glutamate Receptors; Palfreyman, M. G.; Reynolds, I. J.; Skonick, P., Ed.; CRC: New York, 1994; pp 127-135.
10. (b) Ginsberg, M. D. Neuroscientist 1995, 1, 95.
11. (c) Meldrum, B. Clin. Sci. 1985, 68, 113.
12. (d) Rogawski, M. A. Trends Pharmacol. Sci. 1993, 14, 325.
13. (e) McBurney, R. N. Neurobiol. Aging 1994, 15, 271.
14. 5. (a) Witkin, J. M. In CNS Neurotransmitter and Neuromodulators: Glutamate; Stone, T. W., Ed.; CRC: New York, 1995; pp 323-340.
15. (b) Lalonde, R. ibid.; pp 351-357.
16. (c) Moore, K. W.; Leeson, P. D.; Carling, R. W.; Tricklebank, M. D.; Singh, L. Bioorg. Med. Chem. Lett. 1993, 3, 61.
17. (d) Salituro, F. G.; Tomlinson, R. C.; Baron, B. M.; Palfreman, M. G.; McDonald, I. A.; Schmidt, W.; Wu, H.-Q.; Quidetti, P.; Schwarcz, R. J. Med. Chem. 1994, 37, 334.
18. 6. Pelletier, J. C.; Hesson, D. P.; Jones, K. A.; Costa, A.-M. J. Med. Chem. 1996, 39, 343.
19. 7. Although unpublished as a journal article to date, these results were presented by David Hesson at the Neuroscience Meeting in 1995.
20. 8. Comins, D. L.; Brown, J. D. J. Org. Chem. 1989, 54, 3730.
21. 9. Chenard, B. L.; Butler, T. W.; Menniti, F. S.; Prochniak, M. A.; Richter, K. E. G. Bioorg. Med. Chem. Lett. 1993, 3, 1991.
22. 10. (a) Donevan, S. D.; Rogawski, M. A. Neuron 1993, 10, 51-59.
23. (b) Wilding, T. J.; Huettner, J. E. Mol. Pharmacol. 1995, 47, 582.
24. 11. K. Jones, unpublished results.
25. 12. In vivo anticonvulsant models were conducted by the Epilepsy Branch of the National Institute of Health.